News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amarin Corporation PLC (AMRN) Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa™


10/23/2012 8:51:54 AM

BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the U.S. Patent and Trademark Office (USPTO) has issued two patents covering the use of Amarin's VascepaTM (icosapent ethyl) capsules based on U.S. Patent Application Serial Nos. 12/702,889 and 13/349,153, both titled "Methods of Treating Hypertriglyceridemia." On September 5, 2012, Amarin announced the issuance of Notices of Allowance for claims under these applications.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES